Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Interest Income Expense
Charles River Laboratories International Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Interest Income Expense
-$130.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-24%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Interest Income Expense
-$542m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
|
Danaher Corp
NYSE:DHR
|
Interest Income Expense
-$366m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-11%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Interest Income Expense
-$78.4m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
Agilent Technologies Inc
NYSE:A
|
Interest Income Expense
-$24m
|
CAGR 3-Years
28%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Interest Income Expense
-$636m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-18%
|
See Also
What is Charles River Laboratories International Inc's Interest Income Expense?
Interest Income Expense
-130.7m
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Interest Income Expense amounts to -130.7m USD.
What is Charles River Laboratories International Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-24%
Over the last year, the Interest Income Expense growth was -58%. The average annual Interest Income Expense growth rates for Charles River Laboratories International Inc have been -9% over the past three years , -16% over the past five years , and -24% over the past ten years .